About This Educational Activity

Title: You and AML – An Animated Patient's Guide to Acute Myeloid Leukemia (AML)
Launch date: November 27, 2019

Title: You and AML – New Module on Understanding Erythropoiesis
Launch date: March 18, 2021

Title: You and AML – New Modules on Treatment Failure and Relapse in AML, and Maintenance and Continuous Treatment in AML
Launch date: January 26, 2022

This educational activity has been designed to meet the educational needs of patients and caregivers affected by Acute Myeloid Leukemia (AML).

This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.

This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.

Faculty:

Sandra E. Kurtin, PhD, ANP-C, AOCN
Hematology/Oncology Nurse Practitioner
University of Arizona Cancer Center
Clinical Assistant Professor of Medicine
Adjunct Clinical Assistant Professor of Nursing
University of Arizona
Tucson, Arizona

David P. Steensma, MD, FACP
Edward P. Evans Chair of MDS Research
Institute Physician, Department of Medical Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Boston, Massachusetts

Dr. Dale Schaar, MD, PhD
Associate Professor of Medicine, Division of Medical Oncology
Robert Wood Johnson Medical School
Rutgers, The State University of New Jersey
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey

Jamile M. Shammo, MD, FASCP, FACP
Professor of Medicine and Pathology
Rush University Medical Group
Chicago, Illinois

Barry Skikne, MD
Professor of Medicine, Hematology
University of Kansas Medical Center
Kansas City, Kansas

Conflict of Interest Disclosures:

Mechanisms In Medicine Inc. is committed to providing its learners with high quality educational activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this educational activity:

• Dr. Sandra E. Kurtin – Consulting fees received from Agios, Celgene, Celleron, and Jazz Pharmaceuticals.
• Dr. David P. Steensma – Consulting fees received from Astex, Celgene, Onconova, Summer Road, and Takeda. European Hematology Association travel reimbursement received from Janssen.
• Dr. Dale Schaar – Nothing to disclose
• Dr. Jamile M. Shammo – Consulting fees and speaker fees received from Alexion, Apellis, Bristol-Myers Squibb, and Incyte. Research funding received from Abbvie, AstraZeneca, CTI Pharma, Kartos, Novartis, Sanofi, and Stemline. Stockholder: Abbvie, Baxter, Takeda.
• Dr. Barry Skikne – Salary for research and development received from Bristol-Myers Squibb.

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance their own personal development.

• The information presented in this activity is not meant to serve as a guideline for patient management.
• Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should be discussed with your physician.

Technical Requirements:

YouAndAML.com is an internet-based educational program available on Mac and PC. Click here to view Technical Requirements